CATALOGO DEI PRODOTTI DELLA RICERCA

ADAMI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.863
EU - Europa 5.221
AS - Asia 4.364
SA - Sud America 611
Continente sconosciuto - Info sul continente non disponibili 260
AF - Africa 167
OC - Oceania 12
Totale 16.498
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.705
RU - Federazione Russa 2.512
SG - Singapore 1.789
CN - Cina 1.096
IT - Italia 713
GB - Regno Unito 589
BR - Brasile 483
HK - Hong Kong 369
VN - Vietnam 355
DE - Germania 343
SE - Svezia 241
FR - Francia 240
IE - Irlanda 223
IN - India 176
BD - Bangladesh 143
KR - Corea 133
FI - Finlandia 110
CA - Canada 88
JP - Giappone 71
NL - Olanda 49
AR - Argentina 42
MX - Messico 42
PL - Polonia 38
ID - Indonesia 37
ZA - Sudafrica 37
TR - Turchia 36
BJ - Benin 30
NG - Nigeria 30
ES - Italia 29
IQ - Iraq 28
AT - Austria 27
TG - Togo 27
UA - Ucraina 24
CO - Colombia 23
EC - Ecuador 16
UZ - Uzbekistan 16
PH - Filippine 14
PK - Pakistan 14
VE - Venezuela 14
BE - Belgio 11
PE - Perù 10
CH - Svizzera 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
CL - Cile 7
EG - Egitto 7
GR - Grecia 7
IR - Iran 7
KE - Kenya 7
LT - Lituania 7
MY - Malesia 7
PT - Portogallo 7
CR - Costa Rica 6
MA - Marocco 6
PY - Paraguay 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
IL - Israele 5
JO - Giordania 5
KZ - Kazakistan 5
NP - Nepal 5
AL - Albania 4
BO - Bolivia 4
DZ - Algeria 4
HR - Croazia 4
JM - Giamaica 4
NZ - Nuova Zelanda 4
PA - Panama 4
RO - Romania 4
SN - Senegal 4
AM - Armenia 3
BG - Bulgaria 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
KG - Kirghizistan 3
KW - Kuwait 3
LB - Libano 3
LK - Sri Lanka 3
LV - Lettonia 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
UY - Uruguay 3
BS - Bahamas 2
BY - Bielorussia 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
KH - Cambogia 2
ME - Montenegro 2
MK - Macedonia 2
PS - Palestinian Territory 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
BH - Bahrain 1
Totale 16.217
Salva come PNG Salva come JPEG
Città #
Moscow 926
Singapore 912
Ashburn 839
Dallas 652
San Jose 609
Chandler 488
Southend 448
Hong Kong 356
Council Bluffs 306
Dublin 218
Verona 218
Beijing 182
The Dalles 177
New York 164
Los Angeles 140
Ho Chi Minh City 121
Jacksonville 103
Redmond 90
Wilmington 79
Santa Clara 76
Lawrence 74
Princeton 74
Bologna 72
Hanoi 70
Tokyo 69
Buffalo 65
Helsinki 62
Ann Arbor 61
Jinan 60
Munich 59
Shenyang 55
São Paulo 51
Hyderabad 48
London 48
Redondo Beach 48
Nanjing 46
Sindelfingen 46
Orem 43
Milan 40
Tianjin 40
Seattle 37
Woodbridge 35
Falkenstein 34
Hebei 34
Warsaw 34
Columbus 33
Montreal 33
Denver 32
Houston 32
Cotonou 30
Washington 30
Abuja 29
Brooklyn 29
Rome 29
Lomé 27
Zhengzhou 27
Chicago 26
San Francisco 26
Guangzhou 25
Hangzhou 24
Turku 23
Changsha 22
Phoenix 22
Taiyuan 22
Atlanta 21
Haikou 21
Johannesburg 21
Poplar 20
Stockholm 20
Boston 19
Da Nang 19
Nanchang 19
Ningbo 19
Mexico City 18
Amsterdam 17
Jakarta 17
Manchester 17
Chennai 16
Dongguan 16
Tashkent 16
Venice 16
Fairfield 15
Jiaxing 15
Naples 15
Redwood City 15
Mumbai 14
Taizhou 14
Frankfurt am Main 13
Rio de Janeiro 13
Biên Hòa 12
Brasília 11
Lappeenranta 11
Norwalk 11
Seoul 11
Toronto 11
Vienna 11
Belo Horizonte 10
Brussels 10
Miami 10
Ankara 9
Totale 9.473
Salva come PNG Salva come JPEG
Nome #
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 277
Anti-CCP antibodies and bone 247
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 235
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 220
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 206
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 205
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 195
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 195
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 194
Could γ\δ T-cells explain zoledronic acid adverse events? 192
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 192
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 189
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 186
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 186
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 184
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 183
The obesity paradox and osteoporosis 181
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome 177
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 174
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 173
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 172
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 167
Association between environmental air pollution and rheumatoid arthritis flares 167
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 164
Safety issues and adverse reactions with osteoporosis management 162
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 162
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 162
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 162
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 161
Association between acute exposure to environmental air pollution and fragility hip fractures 160
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 159
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 157
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 157
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 156
A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study 155
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 152
Calcium and vitamin D supplementation: when and why 150
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 149
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) 149
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 146
Rheumatoid arthritis, γδ T cells and bisphosphonates 145
Acute Phase Reaction and Fracture Risk Reduction. Are Gamma‐Delta T Cells and hypovitaminosis D the Missing Link? 144
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 143
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? 143
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 141
Changes in bone turnover markers and bone modulators during abatacept treatment 140
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 140
Correction to: The obesity paradox and osteoporosis 140
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 140
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 139
Barnidipine as a potential alternative treatment for Raynaud's phenomenon secondary to systemic sclerosis: a retrospective pilot study 138
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study 136
Osteoporosis in Rheumatic Diseases 136
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 135
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal 134
Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency 133
Bone Loss in Inflammatory Rheumatic Musculoskeletal Disease Patients Treated With Low-Dose Glucocorticoids and Prevention by Anti-Osteoporosis Medications 132
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 132
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 132
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 131
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report 129
Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment 129
Bone health status evaluation in men by means of REMS technology 127
A Prospective Open-Label Observational Study of a Buffered Soluble 70{\hspace{0.167em}}mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The {GastroPASS} Study 126
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 124
Gender disparity in authorship of guidelines and recommendations in rheumatology 122
Efficacy of mud plus bath therapy as compared to bath therapy in osteoarthritis of hands and knees: a pilot single-blinded randomized controlled trial 119
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 116
Glucocorticoid-induced osteoporosis: 2019 concise clinical review 115
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 115
Romosozumab added to ongoing denosumab in postmenopausal osteoporosis, a prospective observational study 114
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs) 114
Pharmacological treatment in adult patients with CRPS-I: A systematic review and meta-analysis of randomised controlled trials 113
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 112
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 112
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs) 111
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 111
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis 107
The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes 104
Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3 104
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 103
Long-Term Bone Mineral Density Changes in Kidney Transplant Recipients Treated with Denosumab: A Retrospective Study with Nonequivalent Control Group 101
Balancing benefits and risks in the era of biologics 100
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 99
Comments on Kanis et al.: Algorithm for the management of patients at low, high, and very high risk of osteoporotic fractures 99
Glucocorticoid sparing effect of Janus Kinase inhibitors compared to biological Disease Modifying Anti-Rheumatic Drugs in rheumatoid arthritis, a single-center retrospective analysis 98
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement 97
Machine learning to characterize bone biomarkers profile in rheumatoid arthritis 97
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 97
Response to: ‘Correspondence on ‘Gender disparity in authorship of guidelines and recommendations in rheumatology’’ by Stewart et al 96
Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life 94
The role of 18FDG-PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature 93
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis 93
Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study 93
Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study 91
Systematic study on nail plate assessment: differences in nail plate shape, thickness, power Doppler signal and scanning approach 90
Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: An analysis on a nation-wide database 90
Radiofrequency echographic multi spectrometry for the prediction of incident fragility fractures: A 5-year follow-up study 89
New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis 87
Long-Term Changes in Parameters of Bone Quality in Kidney Transplant Recipients Treated with Denosumab 86
Totale 14.131
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.562
article - articoli 63.138
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 311
patent - brevetti 0
selected - selezionate 0
volume - volumi 113
Totale 127.124
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022391 0 0 8 20 30 21 15 34 56 20 27 160
2022/20231.499 88 151 118 286 127 345 15 68 170 36 74 21
2023/2024982 40 70 89 125 80 202 54 44 30 43 151 54
2024/20252.632 111 132 104 409 160 79 136 103 402 318 231 447
2025/20268.497 538 391 612 1.453 2.209 542 783 514 518 417 223 297
2026/2027614 172 228 214 0 0 0 0 0 0 0 0 0
Totale 16.498